A PHASE-II STUDY OF WEEKLY 24-HOUR INFUSION WITH HIGH-DOSE FLUOROURACIL WITH LEUCOVORIN IN COLORECTAL-CARCINOMA

被引：225
作者：
ARDALAN, B
CHUA, L
TIAN, EM
REDDY, R
SRIDHAR, K
BENEDETTO, P
RICHMAN, S
LEGASPI, A
WALDMAN, S
MORRELL, L
FEUN, L
SAVARAJ, N
LIVINGSTONE, A
机构：
[1] VET ADM MED CTR,MIAMI,FL 33125
[2] UNIV MIAMI,SCH MED,DEPT ONCOL,MIAMI,FL 33152
[3] UNIV MIAMI,SCH MED,DEPT SURG ONCOL,MIAMI,FL 33152
[4] JACKSON MEM HOSP,MIAMI,FL 33136
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1991年 / 9卷 / 04期
关键词：
D O I：
10.1200/JCO.1991.9.4.625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：625 / 630
页数：6
相关论文
共 21 条
[11]  
KEYOMARSI K, 1986, CANCER RES, V46, P5229
[12]  
MINI E, 1987, CANCER TREAT REP, V71, P381
[13]  
MOERTEL CG, 1977, RECENT ADV CANCER TR, V3, P311
[14]   BIOCHEMICAL DETERMINANTS OF TUMOR SENSITIVITY TO 5-FLUOROURACIL - ULTRASENSITIVE METHODS FOR THE DETERMINATION OF 5-FLUORO-2'-DEOXYURIDYLATE, 2'-DEOXYURIDYLATE, AND THYMIDYLATE SYNTHETASE [J].
MORAN, RG ;
SPEARS, CP ;
HEIDELBERGER, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (03) :1456-1460
[15]   A PROSPECTIVE RANDOMIZED TRIAL OF 5-FLUOROURACIL VERSUS 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN VERSUS 5-FLUOROURACIL AND METHOTREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA [J].
PETRELLI, N ;
HERRERA, L ;
RUSTUM, Y ;
BURKE, P ;
CREAVEN, P ;
STULC, J ;
EMRICH, LJ ;
MITTELMAN, A .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1559-1565
[16]  
SPEARS CP, 1982, CANCER RES, V42, P450
[17]   CYTOTOXICITY OF 5-FLUORO-2'-DEOXYURIDINE - REQUIREMENT FOR REDUCED FOLATE COFACTORS AND ANTAGONISM BY METHOTREXATE [J].
ULLMAN, B ;
LEE, M ;
MARTIN, DW ;
SANTI, DV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (02) :980-983
[18]   FLUOROURACIL AND RECOMBINANT ALFA-2A-INTERFERON - AN ACTIVE REGIMEN AGAINST ADVANCED COLORECTAL-CARCINOMA [J].
WADLER, S ;
SCHWARTZ, EL ;
GOLDMAN, M ;
LYVER, A ;
RADER, M ;
ZIMMERMAN, M ;
ITRI, L ;
WEINBERG, V ;
WIERNIK, PH .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) :1769-1775
[19]  
WAXMAN S, 1978, P AM ASSOC CANC RES, V19, P149
[20]  
WINDSCHITL H, 1983, CANCER TREAT REP, V67, P1001
123